These data significantly demonstrated that inactivated LVP-K1-RBD19 virus can induce neutralizing activities against SARS-CoV-2 in a short period and could be an excellent candidate for COVID-19 vaccine development. The gene discussed is KRT1; the disease is COVID-19.